이창훈
Lee, Chang-Hun학력
- 2002 ~ 2009Johns Hopkins University 박사
- 1996 ~ 2000연세대학교 학사
경력
- 2012 ~ Current대구경북과학기술원 / 조교수
- 2009 ~ 2012존스홉킨스대 / 박사후연구원
- 2001 ~ 2002김앤장 특허법률사무소 / 사무원
- 1998 ~ 2001연세대 / 연구조원
수상실적
- 2019공로상
- 2019우수발표논문상
- 2019최우수 교육상
- 2014공로상
연구실 소개
- Biointerface Structure and Skin Lab
-
Physiology of Skin, Integumentary System and Biological InterfacesDesign of New Drugs, Proteins, Cells and TissuesStructural Biology for Biological InterfacesBioDesign of Skin and Integumentary SystemSynthetic Biology for Skin
- "Update on Strategies to Reduce Early Brain Injury after Subarachnoid Hemorrhage", Current Neurology and Neuroscience Reports, v.25, no.1
- "Mitochondrial-targeted therapies in traumatic brain injury: From bench to bedside", Neurotherapeutics, v.22, no.1
- "Identification and comparison of protein composition of biofilms in response to EGCG from Enterococcus faecalis and Staphylococcus lugdunensis, which showed opposite patterns in biofilm-forming abilities", Biofilm, v.8
- "Antibacterial Immunonegative Coating with Biocompatible Materials on a Nanostructured Titanium Plate for Orthopedic Bone Fracture Surgery", Biomaterials Research, v.28, pp.1799 - 1812
- "Comparative proteomics analysis of biofilms and planktonic cells of Enterococcus faecalis and Staphylococcus lugdunensis with contrasting biofilm-forming ability", PLoS ONE, v.19, no.5 May
연구분야
국가과학기술표준분류
-
LA. 생명과학
-
LA06. 생화학/구조생물학
LA0601. 단백질 구조와 기능
-
-
LC. 보건의료
-
LC03. 신약·의약품개발
LC0310. 단백질의약품
-
12대 국가전략기술 분야
-
첨단바이오
합성생물학
-
첨단바이오
유전자·세포 치료